New versatile genetic test for lymphoid neoplasms supports personalized management of patients

Increasing knowledge about genomic biomarkers has facilitated better monitoring and personalized management of patients with B-cell malignant tumors. A new integrative, capture-based, next-generation sequencing (NGS) panel, LYmphoid NeXt-Generation Sequencing (LYNX), can detect and analyze standard and novel biomarkers in the most common lymphoid neoplasms simultaneously. This represents a crucial step […]

A new tuberculosis treatment pathway

Scientists from the Hackensack Meridian Center for Discovery and Innovation, working with collaborators from across the globe, uncovered the mechanism of action of a novel anti-tuberculosis drug that they have helped develop. The new findings show how the enzyme inhibitor triaza-coumarin, or TA-C, is metabolized by the TB germs, which […]